{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_12316", "batch_size": 200, "batch_pos": 103, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "No high-potency language or potent metaphor used.", "method": "llm_batch", "batch_id": "batch_2_18728", "batch_size": 200, "batch_pos": 57, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb from the specified list paired with scale/impact information.", "method": "llm_batch", "batch_id": "batch_3_19340", "batch_size": 200, "batch_pos": 197, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14192", "batch_size": 200, "batch_pos": 187, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Reports too early to tell manufacturing numbers, but lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_13172", "batch_size": 200, "batch_pos": 183, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_15068", "batch_size": 200, "batch_pos": 139, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "Segment contains 'too early to tell' which is a negation about certainty/knowledge, not risk/impact/evidence/capability.", "method": "llm_batch", "batch_id": "batch_7_7144", "batch_size": 200, "batch_pos": 126, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "no", "rationale": "The segment focuses on uncertainty regarding manufacturing capability, not a positive statement of readiness.", "method": "llm_batch", "batch_id": "batch_8_9068", "batch_size": 200, "batch_pos": 69, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 9, "answer": "no", "rationale": "The segment does not report prices, economic data, or numerical metrics.", "method": "llm_batch", "batch_id": "batch_9_17356", "batch_size": 200, "batch_pos": 73, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 10, "answer": "no", "rationale": "The segment states uncertainty about future manufacturing capacity, not relief from the threat.", "method": "llm_batch", "batch_id": "batch_10_18736", "batch_size": 200, "batch_pos": 49, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 11, "answer": "no", "rationale": "Quote does not contain explicit dominant alarmist or reassuring language about the virus threat.", "method": "llm_batch", "batch_id": "batch_11_14628", "batch_size": 200, "batch_pos": 13, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 12, "answer": "yes", "rationale": "Factual statement about manufacturing uncertainty.", "method": "llm_batch", "batch_id": "batch_12_16232", "batch_size": 200, "batch_pos": 13, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
